Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin +/- Thalidomide in Ovarian Cancer
NCT00004876Phase 2Completed
- Sponsor
- Cancer Research UK
- Start
- Aug 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in ovarian epithelial cancer, sponsored by Cancer Research UK. Started Aug 1999; status: completed.
02
Drugs
thalidomide
03
Conditions
ovarian epithelial cancer
Beyond the preview
Go deeper on NCT00004876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004876.